P. Nyce

Chemical Development of MDL 103371: An N-Methyl-d-Aspartate-Type Glycine Receptor Antagonist for the Treatment of Stroke†

B. Harrison, R. A. Farr, E. Huber, 2000 .

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

J. Kehne, F. Salituro, B. Harrison, 1997, European journal of pharmacology.